{"id":68666,"date":"2023-01-14T05:21:30","date_gmt":"2023-01-14T04:21:30","guid":{"rendered":"https:\/\/www.veeva.com\/eu\/?page_id=68666"},"modified":"2026-05-25T12:23:19","modified_gmt":"2026-05-25T10:23:19","slug":"celerion-enhances-patient-centricity","status":"publish","type":"customer-stories","link":"https:\/\/pantheon.veeva.com\/eu\/customer-stories\/celerion-enhances-patient-centricity\/","title":{"rendered":"Celerion"},"content":{"rendered":"

WHY SITEVAULT eCONSENT?<\/h3>\n

\"A<\/p>\n

With a longstanding digital mindset, Celerion is on a journey to
\nimplement new clinical research technologies to conduct trials
\nfaster and more reliably. They want to get data to clients faster,
\nwhile making it easier for participants to take part in studies.
\nCelerion recognized early on that electronic Consent (eConsent)
\nwould increase efficiency and improve the participant experience.
\nHowever, previous eConsent solutions had been unable to meet
\nthe needs of Phase I studies, which must consent and process
\nlarge volumes of participants, quickly.<\/p>\n

SiteVault eConsent offers Celerion a scalable solution for their fast-paced environment. Easy-to-use editor tools
\nallow Celerion to create pre-approved consent templates that can be quickly adapted for specific study
\nrequirements and easily updated as study requirements change. Patients access their consent documents
\nthrough MyVeeva for Patients, an easy-to-use application where they can view and complete study activities.<\/p>\n

\n“eConsent has been a no-brainer for years, we just didn\u2019t have a tool that was
\nfast enough to work in a phase 1 environment.”
\n \u2014 Staci McDonald, Vice President Global Scientific Clinical Operations, Celerion<\/span>\n<\/p><\/blockquote>\n

THE BURDEN OF PAPER<\/h3>\n

\"A<\/p>\n

Benefits for Participants<\/h2>\n

Celerion has received positive feedback from participants. They found it easy to access, review, and sign
\nconsents through the MyVeeva for Patients app. The documents were clearly structured, and they didn\u2019t need
\nto be carried around for months, unlike the old paper documents.<\/p>\n

There were also a few unexpected surprises in the feedback. Celerion had anticipated that eliminating paper
\ndocuments would benefit participants most. What they learned, however, is that patients place even higher value
\non other types of information shared within the MyVeeva document library. This included the study schedule and
\nphone numbers for the nurse\u2019s line or their study coordinator. However, the number one benefit listed by participants
\nwas having the catering menu available in the MyVeeva for Patients app. This highlights how important it is to
\nthink about participant experience as a whole, not just the aspects directly linked to study activities.<\/p>\n

BENEFITS (PARTICIPANT RANKING)<\/h3>\n

\"A<\/p>\n

\n“It was the easiest thing I did all day!
\nI love no packet of paper to carry around with me for months.
\nAll of my consents are on my phone and easy to access.”
\n \u2014 Study Participants<\/span>\n<\/p><\/blockquote>\n

Benefits for Celerion Teams<\/h2>\n

Printing and copying were eliminated almost overnight. Paper consent processes generate huge volumes
\nof paper, resulting in rooms full of documents and trolleys to wheel them from person to person. If a consent
\nform was misplaced, considerable time was wasted searching until the documents were found. Moving to eConsent changed all that, as documents are automatically filed in the system and instantly available
\nwhenever required.<\/p>\n

Removing the need to print thousands of pages of blank ICFs (informed consent forms) simplified screening
\npreparation. Not only has this saved time, staff also reported how quiet the room is without a copy machine
\nconstantly going, which means they can hear participants better.<\/p>\n

The ability to review data has been a real game-changer for Celerion. Documents are available at the touch of a
\nbutton. This means consents can be conducted in the morning and reviewed by the monitor in the afternoon if
\nrequired. Plus, if a monitor has a question, staff can look up the answer at home, whereas previously they would
\nhave to wait until the next day to go to the data room and check the relevant documents.<\/p>\n

Screening logs have also become much more efficient. Previously, paper logs were completed manually during
\nscreening and were prone to errors, especially dates and consent version numbers. Using SiteVault eConsent, the system automatically completes the subject number, consent signature date,
\nand version number. Monitors can view the information in real-time through a screening log report, with new
\ngroups appended to the report as they are added.<\/p>\n

BENEFITS<\/h3>\n

\"Three<\/p>\n

\n“Paper must be shuttled around from room to room.
\nWe didn\u2019t realize how much efficiency we could gain by removing these steps.”
\n \u2014 Staci McDonald, Vice President Global Scientific Clinical Operations, Celerion<\/span>\n<\/p><\/blockquote>\n

Benefits for Monitors<\/h2>\n

Monitoring efficiency significantly increased with eConsent. Signature dates and times are always legible, and
\n\u2018overwrites\u2019 have been eliminated. Additionally, a report displays the list of participants and their consent version
\nnumber, which was previously challenging to track, especially when there are many different consent versions.<\/p>\n

Most importantly, the number of days monitors spend on-site has reduced as consent forms can be reviewed
\nahead of time. This means only two hours may be required to check critical documents, instead of the previous
\neight, which benefits monitors and their host coordinators.<\/p>\n

IMPRESSIVE VOLUMES AFTER ONE YEAR<\/h3>\n

\"An<\/p>\n

\n“The biggest benefit for monitors and for us is that onsite monitoring
\nis 100% not necessary for eConsents.”
\n \u2014 Staci McDonald, Vice President Global Scientific Clinical Operations, Celerion<\/span>\n<\/p><\/blockquote>\n

Overall outcome<\/h2>\n

The introduction of eConsent has increased efficiencies across the consenting process. Perhaps even more
\nimportantly, it has been well received by study teams, sites, monitors, and participants.<\/p>\n

Celerion report the biggest benefits are as follows:<\/p>\n

    \n
  • Monitoring efficiencies have increased as consent documents can be reviewed ahead of time. Many queries
    \nthat would have previously arisen from basic errors or legibility issues have been eliminated altogether.<\/li>\n
  • Calls to the Recruitment Call Center have reduced significantly as simple questions regarding schedules
    \nand phone numbers can now be easily found in the MyVeeva app.<\/li>\n
  • Electronic consents are automatically filed and can be accessed at any time. This has removed the
    \ninfrequent, but resource-intensive searches that occurred if a consent document was misplaced.<\/li>\n
  • Communication with participants is more efficient. Participants can be kept up to date with schedule
    \nchanges more easily, and the ability to share any document has significantly improved the experience of
    \nparticipating in clinical research.<\/li>\n<\/ul>\n

    BIGGEST IMPACT FOR CELERION<\/h3>\n

    \"Four<\/p>\n","protected":false},"excerpt":{"rendered":"

    Learn how SiteVault eConsent helps Celerion to get data to clients faster, while making it easier for participants to take part in clinical studies.<\/p>\n","protected":false},"featured_media":62488,"parent":0,"template":"","product-link-list":[1393,1447],"class_list":["post-68666","customer-stories","type-customer-stories","status-publish","has-post-thumbnail","hentry","product-link-list-veeva-clinical-operations","product-link-list-veeva-sitevault"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/pantheon.veeva.com\/eu\/wp-json\/wp\/v2\/customer-stories\/68666"}],"collection":[{"href":"https:\/\/pantheon.veeva.com\/eu\/wp-json\/wp\/v2\/customer-stories"}],"about":[{"href":"https:\/\/pantheon.veeva.com\/eu\/wp-json\/wp\/v2\/types\/customer-stories"}],"version-history":[{"count":7,"href":"https:\/\/pantheon.veeva.com\/eu\/wp-json\/wp\/v2\/customer-stories\/68666\/revisions"}],"predecessor-version":[{"id":81404,"href":"https:\/\/pantheon.veeva.com\/eu\/wp-json\/wp\/v2\/customer-stories\/68666\/revisions\/81404"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pantheon.veeva.com\/eu\/wp-json\/wp\/v2\/media\/62488"}],"wp:attachment":[{"href":"https:\/\/pantheon.veeva.com\/eu\/wp-json\/wp\/v2\/media?parent=68666"}],"wp:term":[{"taxonomy":"product-link-list","embeddable":true,"href":"https:\/\/pantheon.veeva.com\/eu\/wp-json\/wp\/v2\/product-link-list?post=68666"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}